5 of the best ASX 200 shares to buy in June

Let's see what brokers are recommending to investors for next month.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

June is just around the corner, and for investors, a new month brings a fresh opportunity to review portfolios, top up high-conviction ideas, and add quality shares for the long haul.

While markets have bounced off their April lows, there's still plenty of ASX 200 shares out there with the potential to deliver strong returns.

Here are five of the best ASX 200 shares to consider buying in June according to analysts.

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

Brickworks Ltd (ASX: BKW)

Brickworks is more than just bricks. It's a diversified business with exposure to building products, property, and investments — including a long-standing stake in Washington H. Soul Pattinson (ASX: SOL). This mix provides steady earnings, strong asset backing, and exposure to Australia's housing and construction cycles.

Bel Potter is a fan of the company and has a buy rating and $32.00 price target on its shares.

REA Group Ltd (ASX: REA)

REA Group is the operator of realestate.com.au, the digital advertising juggernaut that dominates the Australian property listings market. Despite challenges in the property cycle, REA Group has continued to grow through higher ad yields, premium product offerings, and smart technology investments.

Goldman Sachs believes this will continue. It has put a buy rating and $269.00 price target on the ASX 200 share.

Telix Pharmaceuticals Ltd (ASX: TLX)

Another ASX 200 share that gets the thumbs up by analysts is Telix Pharmaceuticals. It is a biotech company with a focus on radiopharmaceutical therapies for cancer diagnostics. Its lead product, Illuccix, is already generating significant (and growing) commercial revenue, and its pipeline of potential therapies could drive further growth in the coming years.

Bell Potter is also a fan of Telix. It has a buy rating and $34.00 price target on its shares.

Woolworths Group Ltd (ASX: WOW)

A fourth ASX 200 share to look at in June is Woolworths. It is the market leader in Australian supermarkets, with strong cash flow, pricing power, and defensive characteristics that shine in uncertain markets. Its trusted brand, loyalty program, and investments in ecommerce and supply chain efficiency give it an edge in the competitive grocery sector.

Goldman Sachs rates Woolworths as a buy with a price target of $36.50.

Xero Ltd (ASX: XRO)

Finally, Xero could be a top ASX 200 share to buy in June. It is a global cloud-based accounting powerhouse, serving millions of small and medium businesses across Australia, New Zealand, the UK, and North America. With a sticky subscription model and an expanding ecosystem of services, Xero is well-positioned to benefit from the ongoing digitisation of small business finance.

Goldman Sachs has a buy rating and $205.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in REA Group and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Brickworks, Goldman Sachs Group, Telix Pharmaceuticals, Washington H. Soul Pattinson and Company Limited, and Xero. The Motley Fool Australia has positions in and has recommended Brickworks, Washington H. Soul Pattinson and Company Limited, and Xero. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »